tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alto Neuroscience initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Patrick Trucchio initiated coverage of Alto Neuroscience (ANRO) with a Buy rating and $10 price target Alto is redefining neuropsychiatric drug development through the application of precision medicine in psychiatry, a “paradigm-shifting approach” that targets biomarker-defined patient populations, the analyst tells investors in a research note. The firm believes the company’s “differentiated” Precision Psychiatry Platform has the potential to optimize patient-treatment matching and outcomes in central nervous system disorders.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1